Scientists are testing technology that could help patients with brain injuries recall lost memories.» Read More
The Cefaly device uses a mild electric current to prevent migraines.
As healthcare reform begins to take shape, venture capitalists see emerging opportunities in digital health start-ups.
Jason Husser, assistant professor of political science at Elon University, tells CNBC's "Cash Flow" that congressional Republicans are too fractious to repeal Obamacare.
Halle Tecco, Founder and CEO of Rock Health, discusses emerging trends in health care in the wake of the Affordable Care Act.
The White House is coming under pressure from some of its closest allies to name a CEO to run its health insurance marketplace.
The vice president of Pornhub.com has offered to help fix glitches plaguing the Obamacare website.
Activist investor Carl Icahn reported a 12.63 stake in medical device maker Hologic, prompting the company to seek protection from a hostile takeover
Johnson & Johnson and its subsidiaries were accused of promoting powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.
JPMorgan Chase, the Bill & Melinda Gates Foundation and others have launched an investment fund focused on late-stage healthcare technology trials.
Jean Michel Karam, CEO of high tech beauty and skin care company, IOMA, talks about how the brand personalizes skin care with a technology also used for airplanes and smartphones.
Scientists have turned human stem cells into pea-sized organs with a neural structure similar to that of a developing embryo.
A new Web company is offering to connect inventors of smaller medical devices with people who can give them the cash they need to get off the ground.
The family of Henrietta lacks, whose immortal cells made billions in medical research, won an ethical victory when they were given some power over HeLa cell information.
Using a technology that echoes science fiction, a company is offering people a place to store their stem cells in a bet that they may one day be used to grow replacement organs.
Transplant experts will meet to decide whether and how to change the rules for children, after the parents of two youngsters successfully sued to get restrictions temporarily lifted.
Time to begin picking through the rubble, looking for stocks that have already been crushed, Cramer said.
Bristol-Myers Squibb and Merck stocks climbed higher Monday as analysts said billions stood to be made from treatment breakthroughs.
Americans accustomed to immediate access to the newest technology may be shocked to find that is not the case when it comes to devices that treat ailing hearts.
Peter Wilmshurst, Portfolio Manager, Templeton Global Equity Group at Franklin Templeton Investments tells CNBC's Cash Flow why he likes pharmaceutical stocks at the moment.
The health-care industry is looking to harness big data, but finding the right workers isn't always easy. In some cases, companies are making acquisitions to bring talent in-house.